Home > Insider Trading > Filing (0001209191-21-053544)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1404644	Neoleukin Therapeutics Inc.	NLTX	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1588467	G Jonathan Drachman	C/O Neoleukin Therapeutics, Inc. 188 East Blaine Street, #450 Seattle WA 98102	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-08-24	100,000	$6.11	2,348,686	No	4	P	Direct
Common Stock	Acquisiton	2021-08-25	25,000	$6.45	25,000	No	4	P	Indirect	See footnote
Common Stock	Acquisiton	2021-08-25	25,000	$6.45	25,000	No	4	P	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Indirect	See footnote
No	4	P	Indirect	See footnote

Footnotes

Represents the weighted average purchase price. The lowest price at which shares were purchased was $6.1099 and the highest price at which shares were purchased was $6.1482. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares purchased at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.
Represents the weighted average purchase price. The lowest price at which shares were purchased was $6.09 and the highest price at which shares were purchased was $6.60.
These securities are held by a spousal limited access trust of which the Reporting Person is the primary beneficiary.
These securities are held by a spousal limited access trust of which the Reporting Person's spouse is the primary beneficiary.